ARS Pharmaceuticals Inc
XNAS: SPRY
ARS Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart
about
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary co...
Read More
8.88
0.03
(0.34%)
4.1M
XNAS Volume
High volume today
XNAS 10 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for ARS Pharmaceuticals Inc is on 13 Nov 2025 for the purpose of ARS Pharmaceuticals Inc Third Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
ARS Pharmaceuticals Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..